Delivery Order SPE2DB22D1106-SPE2DB25FEYL4
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a medical product, and has a ceiling value of $1,106.76. The contract is a firm fixed price delivery order, with a period of performance through May 21, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $2,413.19 and a period of performance through March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp also holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies, with a ceiling value of $1,921.45 and a completion date of January 27, 2025. The contract is a firm fixed-price delivery order type, with no set-aside designation. Amerisourcebergen Drug...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,690.84, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies. The award is a Firm Fixed Price contract with an ultimate completion date of December 15, 2023. This Delivery Order is placed against Amerisourcebergen's existing Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S." The contract has a ceiling value of $3,097.72 and a period of performance through July 19, 2024. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen, through its Corporate Office division, is responsible for delivering the requested eye drops to support federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,235.61, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 10, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.47, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" with a completion date of June 6, 2025. The contract is not set-aside and was awarded on June 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" and has a ceiling value of $1,147.00. The contract is a firm fixed-price delivery order with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,088.64, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S. The contract has an ultimate completion date of June 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S". The contract has a ceiling value of $2,205.07 and an ultimate completion date of December 20, 2024. It is a firm-fixed-price contract, which indicates a predetermined price for the goods or services provided. The contract does not have a set-aside designation, suggesting it was awarded...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYL4Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a medical product, with a ceiling value of $2,944.57 and a completion date of July 18, 2025. The contract is a firm fixed price delivery order, indicating it is part of a larger Indefinite Delivery Contract (IDC) vehicle, specifically the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and running through December 2026. This IDC enables Amerisourcebergen Drug Corp to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract award was not set aside and was competitively awarded, demonstrating Amerisourcebergen Drug Corp's capability to meet federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/17/25 |